• Scientist

    Job Locations US-MA-Lexington
    Job ID
  • Overview

    We are seeking a highly motivated Associate Scientist to join the Vaccine Research group (Cancer Immunology) at Agenus, Lexington, MA. A strong background in vaccine research in oncology or infectious disease as evidenced by peer reviewed publications or sustained contributions in the biopharmaceutical industry is required for this position. 


    The successful candidate will be responsible for evaluation of both personalized and non-personalized synthetic/recombinant, cancer vaccine candidates in animal models as stand-alone therapeutics and in combination with other immune modulating agents. Evaluation of the company’s existing adjuvants and exploration of other adjuvants will be an important component of this research. He/she will be expected to design, execute and interpret high quality experiments with moderate supervision in the collaborative global research environment at Agenus.



    • Design and execute research plans with moderate supervision in an organized manner within agreed timelines, while maintaining clear and accurate research documentation
    • Participate in multidisciplinary team meetings as an individual contributor
    • Contribute in the development and implementation of the cancer immunology research strategy at Agenus
    • Evaluate immune readouts (PD endpoints) that can be incorporated in an early clinical development setting
    • Demonstrate excellent communication skills (interpersonal and in group forums)


    A PhD with 0-2 years post-doctoral training (academic or industrial) in molecular immunology, molecular oncology cancer immunology or infectious disease models is required, or Master’s degree with 5+ years directly related experience. Experience with murine disease models and related immune monitoring assays are required skills. Candidates should have excellent communication skills, be able to distill complex ideas and articulate innovative solutions, and be dedicated to translating basic translational research insights into impactful human therapies.




    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed